Showing results (211-220 of 398) with videos related to
Sort By:
Pageof 40
BMC Urology|May 5, 2019
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancerSang Eun Yoon, Youjin Kim, Jangho Cho, et al.Molecular Cancer Therapeutics|September 25, 2014
Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines with FGFR2 amplificationSeung Tae Kim, Hye-Lim Jang, Su Jin Lee, et al.BMC Urology|August 24, 2017
A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancerHae Su Kim, Ji Yun Lee, Su Jin Lee, et al.Journal of Cancer|October 5, 2016
Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric CancerHa Yeon Lee, In Gyu Hwang, Song-Ee Park, et al.Lung Cancer (Amsterdam, Netherlands)|March 18, 2008
Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancerSe Hoon Park, Junshik Hong, Young Saing Kim, et al.JCO Precision Oncology|September 14, 2020
Mechanisms of Acquired Resistance to Savolitinib, a Selective MET Inhibitor in <i>MET</i>-Amplified Gastric CancerMelanie M Frigault, Aleksandra Markovets, Barrett Nuttall, et al.Oncotarget|December 30, 2017
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell linesJung Eun Kim, Youjin Kim, Gary Li, et al.Cancer Chemotherapy and Pharmacology|March 10, 2010
Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seedingMoon Ki Choi, Byung-Jin Ahn, Dong-Seok Yim, et al.Oncotarget|December 13, 2017
MerTK is a novel therapeutic target in gastric cancerJun Ho Yi, Jiryeon Jang, Jeonghee Cho, et al.Cancer Chemotherapy and Pharmacology|February 9, 2008
Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancerSe Hoon Park, Eun Kyung Cho, Yujin Kim, et al.Pageof 40